Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 7 | 2026 | 39 | 2.480 |
Why?
|
| Macrophages | 6 | 2025 | 40 | 1.890 |
Why?
|
| Cell Proliferation | 4 | 2025 | 143 | 1.540 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 36 | 1.260 |
Why?
|
| Albuminuria | 3 | 2020 | 31 | 1.200 |
Why?
|
| Aortic Diseases | 2 | 2025 | 6 | 1.160 |
Why?
|
| Apoptosis | 4 | 2025 | 179 | 0.980 |
Why?
|
| Nicotinamide N-Methyltransferase | 1 | 2025 | 2 | 0.940 |
Why?
|
| NAD | 1 | 2025 | 3 | 0.940 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2025 | 31 | 0.910 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2025 | 27 | 0.880 |
Why?
|
| Endothelial Cells | 2 | 2024 | 17 | 0.870 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2020 | 5 | 0.790 |
Why?
|
| Diabetic Nephropathies | 2 | 2023 | 56 | 0.780 |
Why?
|
| Vitamin D Deficiency | 1 | 2022 | 24 | 0.740 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 30 | 0.650 |
Why?
|
| Male | 13 | 2026 | 3671 | 0.650 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 172 | 0.640 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 35 | 0.640 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 279 | 0.630 |
Why?
|
| Animals | 12 | 2026 | 1875 | 0.600 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 231 | 0.580 |
Why?
|
| Mice, Inbred C57BL | 7 | 2026 | 258 | 0.560 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 293 | 0.520 |
Why?
|
| Mice | 9 | 2026 | 746 | 0.520 |
Why?
|
| Female | 9 | 2025 | 4060 | 0.520 |
Why?
|
| Mice, Knockout | 5 | 2025 | 150 | 0.500 |
Why?
|
| African Americans | 1 | 2019 | 264 | 0.480 |
Why?
|
| Diabetes Complications | 1 | 2014 | 41 | 0.410 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2025 | 29 | 0.410 |
Why?
|
| Aorta | 2 | 2025 | 20 | 0.400 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2024 | 28 | 0.380 |
Why?
|
| Biomarkers | 3 | 2023 | 214 | 0.370 |
Why?
|
| Humans | 10 | 2025 | 6794 | 0.360 |
Why?
|
| Cell Count | 1 | 2011 | 18 | 0.350 |
Why?
|
| Podocytes | 1 | 2011 | 11 | 0.350 |
Why?
|
| Aged | 4 | 2020 | 1539 | 0.320 |
Why?
|
| Follistatin | 2 | 2026 | 18 | 0.320 |
Why?
|
| Cells, Cultured | 4 | 2025 | 234 | 0.310 |
Why?
|
| Middle Aged | 4 | 2020 | 2108 | 0.300 |
Why?
|
| Receptors, LDL | 3 | 2026 | 6 | 0.290 |
Why?
|
| Adult | 3 | 2020 | 2113 | 0.290 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 420 | 0.280 |
Why?
|
| Mice, Knockout, ApoE | 2 | 2025 | 10 | 0.270 |
Why?
|
| Nicotine | 2 | 2020 | 144 | 0.270 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 67 | 0.260 |
Why?
|
| Arginine | 1 | 2026 | 20 | 0.250 |
Why?
|
| Adipose Tissue, Brown | 1 | 2026 | 16 | 0.240 |
Why?
|
| Inflammation | 2 | 2024 | 143 | 0.240 |
Why?
|
| Bone Marrow Transplantation | 1 | 2025 | 4 | 0.240 |
Why?
|
| Signal Transduction | 4 | 2025 | 246 | 0.230 |
Why?
|
| Methylamines | 1 | 2025 | 1 | 0.230 |
Why?
|
| Oxysterols | 1 | 2024 | 1 | 0.220 |
Why?
|
| Diet, High-Fat | 2 | 2024 | 59 | 0.210 |
Why?
|
| Pulse Wave Analysis | 1 | 2022 | 1 | 0.190 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2022 | 2 | 0.190 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2022 | 5 | 0.190 |
Why?
|
| Fibroblast Growth Factors | 1 | 2022 | 10 | 0.190 |
Why?
|
| Cholecalciferol | 1 | 2022 | 8 | 0.190 |
Why?
|
| Vitamins | 1 | 2022 | 14 | 0.190 |
Why?
|
| Parathyroid Hormone | 1 | 2022 | 44 | 0.180 |
Why?
|
| Creatinine | 2 | 2019 | 48 | 0.170 |
Why?
|
| Mice, 129 Strain | 1 | 2020 | 5 | 0.170 |
Why?
|
| Animal Feed | 1 | 2020 | 11 | 0.170 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 7 | 0.170 |
Why?
|
| Cadherins | 1 | 2020 | 4 | 0.170 |
Why?
|
| Muscle Proteins | 1 | 2020 | 13 | 0.170 |
Why?
|
| Antigens, CD | 1 | 2020 | 21 | 0.170 |
Why?
|
| Machine Learning | 1 | 2020 | 12 | 0.160 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 127 | 0.160 |
Why?
|
| Urinalysis | 1 | 2019 | 5 | 0.150 |
Why?
|
| Risk Assessment | 1 | 2020 | 197 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 13 | 0.150 |
Why?
|
| Glycated Hemoglobin A | 1 | 2019 | 65 | 0.150 |
Why?
|
| Stroke Volume | 1 | 2019 | 20 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 21 | 0.150 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 140 | 0.150 |
Why?
|
| Vaping | 1 | 2019 | 26 | 0.150 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 169 | 0.150 |
Why?
|
| Incidence | 1 | 2019 | 197 | 0.150 |
Why?
|
| Nicotinic Agonists | 1 | 2019 | 38 | 0.140 |
Why?
|
| Zinc Fingers | 1 | 2018 | 2 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 11 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 170 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 506 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2018 | 53 | 0.140 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2019 | 58 | 0.140 |
Why?
|
| Risk Factors | 1 | 2020 | 767 | 0.140 |
Why?
|
| United States | 1 | 2020 | 1019 | 0.120 |
Why?
|
| Neointima | 1 | 2016 | 4 | 0.120 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 3 | 0.120 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 1 | 0.120 |
Why?
|
| Osteoclasts | 1 | 2015 | 2 | 0.120 |
Why?
|
| Giant Cells | 1 | 2015 | 2 | 0.120 |
Why?
|
| Calcinosis | 1 | 2015 | 12 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 115 | 0.100 |
Why?
|
| Young Adult | 1 | 2014 | 567 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 7 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 9 | 0.090 |
Why?
|
| Microtomy | 1 | 2011 | 2 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2011 | 10 | 0.090 |
Why?
|
| Estradiol | 1 | 2011 | 57 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 118 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 120 | 0.090 |
Why?
|
| gamma-MSH | 1 | 2009 | 1 | 0.080 |
Why?
|
| Receptor, Melanocortin, Type 3 | 1 | 2009 | 1 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2020 | 102 | 0.080 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 20 | 0.070 |
Why?
|
| beta Catenin | 1 | 2008 | 15 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2009 | 112 | 0.070 |
Why?
|
| Androgens | 1 | 2008 | 24 | 0.070 |
Why?
|
| Muscle Development | 1 | 2008 | 19 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 55 | 0.070 |
Why?
|
| Kidney | 1 | 2009 | 184 | 0.070 |
Why?
|
| Dependovirus | 1 | 2026 | 8 | 0.060 |
Why?
|
| Arginase | 1 | 2026 | 6 | 0.060 |
Why?
|
| Uncoupling Protein 1 | 1 | 2026 | 12 | 0.060 |
Why?
|
| Adipose Tissue, White | 1 | 2026 | 9 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 2 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2025 | 8 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2024 | 22 | 0.050 |
Why?
|
| Osteopontin | 1 | 2023 | 1 | 0.050 |
Why?
|
| Rats | 2 | 2016 | 571 | 0.040 |
Why?
|
| Mecamylamine | 1 | 2020 | 8 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2020 | 18 | 0.040 |
Why?
|
| Imidazoles | 1 | 2020 | 13 | 0.040 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2020 | 9 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2020 | 10 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 24 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 21 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 24 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 94 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 156 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 9 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 9 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 45 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 23 | 0.040 |
Why?
|
| Transcriptome | 1 | 2019 | 31 | 0.040 |
Why?
|
| Mutation | 1 | 2019 | 97 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 46 | 0.040 |
Why?
|
| Gene Expression | 1 | 2018 | 77 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2016 | 16 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 48 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 282 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 65 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 497 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 1 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 8 | 0.020 |
Why?
|
| Monocytes | 1 | 2011 | 14 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 35 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 321 | 0.020 |
Why?
|
| Telemetry | 1 | 2009 | 2 | 0.020 |
Why?
|
| Rats, Inbred Dahl | 1 | 2009 | 2 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2009 | 3 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2009 | 26 | 0.020 |
Why?
|
| Proteinuria | 1 | 2009 | 15 | 0.020 |
Why?
|
| Sodium | 1 | 2009 | 43 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 110 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 57 | 0.020 |
Why?
|
| Transcription Factor 4 | 1 | 2008 | 3 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 4 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 8 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 5 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 5 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 23 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 25 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 26 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 38 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 101 | 0.020 |
Why?
|